Aberrant Lipid Metabolism ID’d in Early-Stage Lung Cancer – Physician’s Weekly
THURSDAY, Feb. 3, 2022 (HealthDay News) — A plasma assay that detects dysregulated lipids has potential as a screening method for early-stage lung cancer,…
Select Page
Feb 3, 2022
THURSDAY, Feb. 3, 2022 (HealthDay News) — A plasma assay that detects dysregulated lipids has potential as a screening method for early-stage lung cancer, according to a study published in the Feb. 2 issue of Science Translational Medicine.
